BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11986221)

  • 1. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia.
    Costello RT; Sivori S; Marcenaro E; Lafage-Pochitaloff M; Mozziconacci MJ; Reviron D; Gastaut JA; Pende D; Olive D; Moretta A
    Blood; 2002 May; 99(10):3661-7. PubMed ID: 11986221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
    Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
    Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias.
    Nowbakht P; Ionescu MC; Rohner A; Kalberer CP; Rossy E; Mori L; Cosman D; De Libero G; Wodnar-Filipowicz A
    Blood; 2005 May; 105(9):3615-22. PubMed ID: 15657183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
    Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
    Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines.
    Sivori S; Parolini S; Marcenaro E; Castriconi R; Pende D; Millo R; Moretta A
    J Neuroimmunol; 2000 Jul; 107(2):220-5. PubMed ID: 10854660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.
    Le Maux Chansac B; Moretta A; Vergnon I; Opolon P; Lécluse Y; Grunenwald D; Kubin M; Soria JC; Chouaib S; Mami-Chouaib F
    J Immunol; 2005 Nov; 175(9):5790-8. PubMed ID: 16237071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients.
    Fauriat C; Moretta A; Olive D; Costello RT
    Blood; 2005 Sep; 106(6):2186-8. PubMed ID: 15928036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.
    Siegler U; Kalberer CP; Nowbakht P; Sendelov S; Meyer-Monard S; Wodnar-Filipowicz A
    Leukemia; 2005 Dec; 19(12):2215-22. PubMed ID: 16224486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells.
    Vitale M; Zimmer J; Castriconi R; Hanau D; Donato L; Bottino C; Moretta L; de la Salle H; Moretta A
    Blood; 2002 Mar; 99(5):1723-9. PubMed ID: 11861289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective cross-talk among natural cytotoxicity receptors in human natural killer cells.
    Augugliaro R; Parolini S; Castriconi R; Marcenaro E; Cantoni C; Nanni M; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2003 May; 33(5):1235-41. PubMed ID: 12731048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
    Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
    J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human natural cytotoxicity receptors (NCR) that induce HLA class I-independent NK cell triggering.
    Bottino C; Biassoni R; Millo R; Moretta L; Moretta A
    Hum Immunol; 2000 Jan; 61(1):1-6. PubMed ID: 10658972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NK cell-mediated lysis of autologous antigen-presenting cells is triggered by the engagement of the phosphatidylinositol 3-kinase upon ligation of the natural cytotoxicity receptors NKp30 and NKp46.
    Spaggiari GM; Carosio R; Pende D; Marcenaro S; Rivera P; Zocchi MR; Moretta L; Poggi A
    Eur J Immunol; 2001 Jun; 31(6):1656-65. PubMed ID: 11385609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.
    Braciak TA; Wildenhain S; Roskopf CC; Schubert IA; Fey GH; Jacob U; Hopfner KP; Oduncu FS
    J Transl Med; 2013 Nov; 11():289. PubMed ID: 24237598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
    Nattermann J; Feldmann G; Ahlenstiel G; Langhans B; Sauerbruch T; Spengler U
    Gut; 2006 Jun; 55(6):869-77. PubMed ID: 16322112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human natural killer cell receptors and co-receptors.
    Biassoni R; Cantoni C; Pende D; Sivori S; Parolini S; Vitale M; Bottino C; Moretta A
    Immunol Rev; 2001 Jun; 181():203-14. PubMed ID: 11513142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
    Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
    Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44).
    De Maria A; Fogli M; Costa P; Murdaca G; Puppo F; Mavilio D; Moretta A; Moretta L
    Eur J Immunol; 2003 Sep; 33(9):2410-8. PubMed ID: 12938217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.